Benefits
Sugar replacement with minimal calories
Allulose tastes and behaves similarly to table sugar but contributes virtually no calories. It works well in beverages, baked goods, and condiments for people cutting added sugar. It is not quite a one-for-one swap by sweetness, though: because allulose is only about 70 percent as sweet as sugar, you generally need somewhat more of it to reach the same sweetness.
Supports healthy blood glucose
This is the best supported effect on the page. In an acute trial in 20 healthy adults, 2.5 to 7.5 g of allulose added to a 75 g maltodextrin drink lowered the glucose rise from that drink, with larger doses doing more. A meta-analysis pooling 40 trial comparisons found allulose cut the post-meal glucose curve by roughly 10 percent, and a separate meta-analysis in healthy adults reached the same conclusion. Trials have also been run in people with borderline diabetes and in people with type 2 diabetes and found similar post-meal improvements, but those are findings in people who already have a blood sugar problem rather than a promise for everyone else.
Supports post-meal fat burning
None of the human studies cited on this page measured GLP-1 or any other gut hormone, so a GLP-1 claim is not supported here. What was actually measured: in a crossover trial in 13 healthy adults, 5 g of allulose taken with a standard meal increased fat burning after the meal and shifted the body toward using less carbohydrate for fuel. That was a single-meal measurement in a small group, not a long-term appetite or weight result.
Supports weight management efforts
Swapping allulose in for sugar cuts calories and added sugar, which is the main way it can help. Beyond that, one 12-week randomized, double-blind, placebo-controlled trial in 121 Korean adults with a BMI of 23 or higher tested 4 g or 7 g twice a day and found significant reductions in body fat percentage and fat mass, with CT scans showing less abdominal and under-the-skin fat at the higher dose. The authors themselves called it a preliminary study, and it is the only trial of its kind cited here.
Tooth-friendly sweetness
Cavity-causing mouth bacteria do not readily ferment allulose, so it should contribute far less plaque acid than table sugar. This is based on laboratory testing of bacteria rather than on any dental trial, and none of the studies cited on this page measured cavities or plaque in people.
Mechanism of action
Absorbed but not metabolized
Allulose is absorbed in the small intestine via GLUT5 and other hexose transporters but is not used efficiently as an energy source. The majority is excreted unchanged in urine within 24 hours, which underlies its near-zero caloric contribution.
Post-meal fuel use
GLP-1 release from intestinal cells is often proposed as the explanation for allulose's effects, but no human study cited on this page measured GLP-1 or any other incretin hormone, so this stays a hypothesis. What human measurements do show is that allulose taken with a meal lowers the glucose rise from that meal and increases post-meal fat burning, without raising blood glucose itself.
Hepatic glucose handling
This is animal and laboratory work only, not human data. Rodent studies suggest allulose can act on liver enzymes involved in glucose metabolism, including glucokinase and the enzymes that build new glucose. No human study cited on this page tested liver enzyme activity, so treat this as a proposed explanation rather than something shown to happen in people.
Lack of fermentation by oral bacteria
Cavity-causing mouth bacteria such as Streptococcus mutans do not readily ferment allulose into acid in laboratory testing, so allulose-sweetened products should produce less plaque acid than sugar. This comes from lab work on bacteria in a dish, and none of the human studies cited on this page looked at teeth, plaque, or cavities.
Clinical trials
Two Japanese randomized trials. One gave 2.5 to 7.5 g of D-psicose along with a 75 g maltodextrin drink. The other gave 5 g with a standard meal and also followed normal subjects taking it daily over a longer period to check safety.
20 healthy adults in the first trial; people with borderline diabetes in the second.
Allulose lowered the post-meal glucose curve compared with control, and larger doses lowered it more. In the borderline diabetes trial, 5 g with a meal significantly reduced blood glucose at 30 and 60 minutes. The 12-week safety arm in normal subjects reported no adverse effects. These are single-meal blood sugar measurements in small groups, and they are not evidence that allulose treats or prevents diabetes or any other disease.
Randomized, double-blind, placebo-controlled trial testing 4 g or 7 g of allulose twice daily against placebo.
121 Korean adults with a BMI of 23 or higher.
Body fat percentage and fat mass fell significantly versus placebo, and CT scans confirmed less abdominal and under-the-skin fat at the higher dose. The trial also found no significant differences between groups in what people ate, in blood lipids, in liver or kidney function markers, or in the main inflammation markers measured. The authors describe it as a preliminary study, so treat the fat-loss result as promising rather than settled.